SFS
RPRX icon

Sowell Financial Services’s Royalty Pharma RPRX Stock Holding History

Sowell Financial Services’s Portfolio RPRX Stock Details RPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$418K Sell
7,456
-369
-5% -$19.2K 0.01% 724
2026
Q1 		$375K Buy
7,825
+191
+3% +$8.37K 0.01% 747
2025
Q4 		$295K Buy
7,634
+870
+13% +$33.2K 0.01% 842
2025
Q3 		$239K Sell
6,764
-354
-5% -$12.8K 0.01% 913
2025
Q2 		$256K Buy
7,118
+43
+0.6% +$1.43K 0.01% 864
2025
Q1 		$220K Buy
+7,075
New +$224K 0.01% 896

Other funds holding RPRX

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Sowell Financial Services's RPRX Position: Q2 2026 in Review

Sowell Financial Services reduced its Royalty Pharma (RPRX) stake by 4.7% in Q2 2026, selling an estimated $19.2K and leaving 7,456 shares worth $418K. The position accounts for 0.01% of the portfolio, ranked #724.

Sowell Financial Services first reported a position in RPRX in Q1 2025 and has held it in 6 quarters since. 642 funds tracked by Wall St. Rank hold RPRX as of Q2 2026.

  • Sowell Financial Services held 7,456 shares of Royalty Pharma worth $418K as of Q2 2026.
  • Sowell Financial Services sold 369 Royalty Pharma shares in Q2 2026, an estimated $19.2K.
  • Royalty Pharma made up 0.01% of Sowell Financial Services's portfolio in Q2 2026, its #724 holding.
  • Sowell Financial Services first reported a position in Royalty Pharma in Q1 2025 and has held it in 6 quarters since.
  • 642 funds tracked by Wall St. Rank held Royalty Pharma as of Q2 2026.

Based on Sowell Financial Services's 13F filing for Q2 2026, filed 20 Jul 2026.